BioSpace News Archive

Company Sees Significant Growth Opportunity in Asia

Genomind®, an award-winning company advancing a unique personalized medicine platform, has strengthened its leadership with the appointment of two experienced global leaders, Shawn Patrick O’Brien as CEO, and Kip Olmstead as President, as well as the promotion of David Robbins to Chief Scientific Officer.

ST. LOUIS, /PRNewswire/ -- Controlling nematodes in a new planting is standard operating procedure in tree crop production. Knocking down those insidious pests when pressure rebuilds in the established orchard was the challenge - was the challenge.

Science and Nature in Perfect Rhythm

ImpediMed Limited (ASX: IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid status using bioimpedance spectroscopy (BIS), announces that the first patient has been enrolled in its 200-patient Heart Failure (HF) trial now being conducted at Scripps Memorial Hospital, San Diego, CA.

The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain nanoantibody (nAb) therapies for the treatment of sepsis.

Partnership and Investment Fuel Plans for Upcoming Advancements

Innovus Pharmaceuticals, Inc. today announced the approval from Amazon® for the expansion of its Amazon® stores to Japan.

Company unveils three new brands exclusive to the Canadian adult-use market

Soligenix, Inc. announced today it has received a positive recommendation from the independent Data Monitoring Committee (DMC) to continue enrolling into the Company’s Phase 3 “Fluorescent Light Activated Synthetic Hypericin” (FLASH) study for SGX301 (synthetic hypericin) in the treatment of cutaneous T-cell lymphoma (CTCL).